Korea / Special Sits, Pairs, Index Rebalancing, Clepsydra Capital

Sanghyun Park

I investigate special situations, pairs, and index rebalancing trades in Korea.

Korea / Special Sits, Pairs, Index Rebalancing

Celltrion Healthcare IPO, Unlikely to Have Owner Premium Factor

Event-Driven

<p>How should we interpret Teva's potential acquisition of Celltrion? Is this for real? Well, Teva may still be very interested in acquiring Celltrion since this may be the most effective way to improve its biosimilar business, which is viewed as one of the key growth engines for Teva. But Celltrion's major shareholder may have a different intention on this. Now, let's take a look at this issue more closely.</p><p>Celltrion gained 7% Tuesday on positive expectations for Inflectra's sales in the US. Pfizer…</p>

How should we interpret Teva's potential acquisition of Celltrion? Is this for real? Well, Teva may still be very interested in acquiring Celltrion since this may be the most effective way to improve its biosimilar business, which is viewed as one of the key growth engines for Teva. But Celltrion's major shareholder may have a different intention on this. Now, let's take a look at this issue more closely.Celltrion gained 7% Tuesday on positive expectations for Inflectra's sales in the US. Pfizer…

Teva May Buy Celltrion - Implications for Celltrion & Celltrion Healthcare

Celltrion Inc

Teva May Buy Celltrion - Implications for Celltrion & Celltrion Healthcare